Department of Molecular Physiology and Biophysics
-
October 16, 2013
Relaxin combats insulin resistance
The hormone relaxin may offer a novel approach for treating diet-induced insulin resistance. -
September 19, 2013
Transporter linked to autism risk
Vanderbilt University investigators for the first time have linked a non-inherited, de novo mutation in the dopamine transporter to autism spectrum disorder (ASD). -
August 9, 2013
‘Yo-yo dieting’ inflames fat tissue
Gaining and losing weight during “yo-yo dieting” may contribute to an exaggerated immune response in fat tissue that increases metabolic dysfunction more than steady weight gain alone. -
June 6, 2013
Matrix member key to insulin resistance
A component of the extracellular matrix that surrounds cells plays a role in insulin resistance and may be a good therapeutic target. -
January 20, 2012
Digestive disease research bolstered by grant renewal
The Vanderbilt Digestive Disease Research Center celebrates its 10th anniversary this year with a second five-year renewal of its federal research grant.